Surgical treatment of liver metastases from colorectal carcinoma;Il trattamento chirurgico delle metastasi epatiche da carcinoma del colon-retto

Minerva Chirurgica

Volumn 62, Issue 4, 2007, Pages 257-267

  Donadon, M ^a   Torzilli, G ^a  

^a HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

Author keywords

Colonic neoplasms; Liver neoplasms, surgery; Metastases; Rectal neoplasms; Survival

Indexed keywords

ANTINEOPLASTIC AGENT;

ARTICLE; CARCINOMA; COLORECTAL TUMOR; HUMAN; LIVER RESECTION; LIVER TUMOR; METASTASIS; PATHOLOGY; PREOPERATIVE CARE; STANDARD; SURVIVAL; TREATMENT OUTCOME;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA; COLORECTAL NEOPLASMS; HEPATECTOMY; HUMANS; LIVER NEOPLASMS; PREOPERATIVE CARE; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 36649021117     PISSN: 00264733     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (65)

1. Jemal A, Tiwari RC, Murray T, Ghafoor A, Samuels A, Ward E et al. Cancer statistics, 2004. CA Cancer J Clin 2004;54:8-29.
2. Scheele J, Stangl R, Altendorf-Hofmann A. Hepatic metastases from colorectal carcinoma: impact of surgical resection on the natural history. Br J Surg 1990;77: 1241-6.
3. Venook A. Critical evaluation of current treatments in metastatic colorectal cancer. Oncologist 2005;10:250-61.
4. Choti MA, Sitzmann JV, Tiburi MF, Sumetchotimetha W, Rangsin R, Schulick RD et al. Trends in long-term survival following liver resection for hepatic colorectal metastases. Ann Surg 2002;235:759-66.
5. Fernandez FG, Drebin JA, Linehan DC, Dehdashti F, Siegel BA, Strasberg SM. Five-year survival after resection of hepatic metastases from colorectal cancer in patients screened by positron emission tomography with F-18 fluorodeoxyglucose (FDG-PET). Ann Surg 2004;240:438-47.
6. Abdalla EK, Vauthey JN, Ellis LM, Ellis V, Pollock R, Broglio KR et al. Recurrence and outcome following hepatic resection, radiofrequency ablation and combined resection/ablation for colorectal liver metastases. Ann Surg 2004;239:818-27.
7. Pawlik TM, Scoggins CR, Zorzi D, Abdalla EK, Andres A, Eng C et al. Effect of surgical margin status on survival and site of recurrence after hepatic resection for colorectal metastases. Ann Surg 2005;241:715-24.
8. Quaia E, Calliada F, Bertolotto M, Rossi S, Garioni L, Rosa L et al. Characterization of focal liver lesions with contrast-specific US modes and a sulfur hexafluoridefilled microbubble contrast agent: diagnostic performance and confidence. Radiology 2004;232:420-30.
9. Bipat S, van Leeuwen MS, Coman EFI, Piji ME, Bossuyt PM, Zwinderman AH et al. Colorectal liver metastases: CT, MR imaging, and PET for diagnosis-metaanalysis. Radiology 2005;237:123-31.
10. Namkung S, Zech CJ, Helmberger T, Reiser MF, Schoenberg SO. Superparamagnetic iron oxide (SPIO)-enhanced liver MRI with ferucarbotran: efficacy for characterization of focal liver lesions. J Magn Reson Imaging 2007;25:755-65.
11. Akhurst T, Kates TJ, Mazumdar M, Yeung H, Riedel ER, Burt BM et al. Recent chemotherapy reduces the sensitivity of [18F] fluorodeoxyglucose positron emission tomography in the detection of colorectal metastases. J Clin Oncol 2005;23:8713-61.
12. Selzner M, Thomas F, Hany TF, Wildbrett P, Lucas McCormack L et al. Does the novel PET/CT imaging modality impact on the treatment of patients with metastatic colorectal cancer of the liver? Ann Surg 2004;240:1027-36.
13. Hatano E, Ikai I, Higashi T, Teramukai S, Torizuka T, Saga T et al. Preoperative positron emission tomography with fluorine 18-florodeoxyglucose is predictive of prognosis in patients with hepatocellular carcinoma after resection. World J Gastroenterol 2006;30: 1735-41.
14. D'Angelica M, Fong Y, Weber S, Gonen M, DeMatteo RP, Conlon K et al. The role of staging laparoscopy in hepatobiliary malignancy: prospective analysis of 401 cases. Ann Surg Oncol 2003;10:183-9.
15. Makuuchi M, Hasegawa H, Yamazaki S. Intraoperative ultrasonic examination for hepatectomy. Jpn J Clin Oncol 1981;11:367-90.
16. Conlon R, Jacobs M, Dasgupta D, Lodge JP. The value of intraoperative ultrasound during hepatic resection compared with improved preoperative magnetic resonance imaging. Eur J Ultrasound 2003;16:211-6.
17. Torzilli G, Makuuchi M. Intraoperative ultrasonography in liver cancer. Surg Oncol Clin North Am 2003;12:91-103.
18. Machi J, Isomoto H, Kurohiji T, Yamashita Y, Shirouzu K, Kakegawa T et al. Accuracy of intraoperative ultrasonography in diagnosing liver metastasis from colorectal cancer: evaluation with postoperative follow-up results. World J Surg 1991;15:551-6.
19. Torzilli G, Del Fabbro D, Olivari N, Calliada F, Montorsi M, Makuuchi M. Contrast-enhanced ultrasonography during liver surgery. Br J Surg 2004;91:1165-7.
20. Torzilli G, Del Fabbro D, Palmisano A, Donadon M, Bianchi P, Roncalli M et al. Contrast-enhanced intraoperative ultrasonography during hepatectomies for colorectal cancer liver metastases. J Gastrointest Surg 2005;9:1148-53.
21. Jaeck D. The significance of hepatic pedicle lymph node metastases in surgical management of colorectal liver metastases and of other liver malignancies. Ann Surg Oncol 2003;10:1007-11.
22. Elias D, Sideris L, Pocard M, Ouellet JF, Boige V, Lasser P et al. Results of RO resection for colorectal liver metastases associated with extrahepatic disease. Ann Surg Oncol 2004;11:274-80.
23. Minagawa M, Makuuchi M, Torzilli G, Takayama T, Kawasaki S, Kosuge T et al. Extension of the frontiers of surgical indications in the treatment of liver metastases from colorectal cancer: long-term results. Ann Surg 2000;231:487-99.
24. Pawlik TM, Abdalla EK, Ellis LM, Vauthey JN, Curley SA. Debunking dogma: surgery for four or more colorectal liver metastases is justified. J Gastrointestinal Surg 2006;10:240-8.
25. Kokudo N, Imamura H, Sugawara Y, Sakamoto Y, Yamamoto J, Seki M et al. Surgery for multiple hepatic colorectal metastases. J Hepatobiliary Pancreat Surg 2004;11:84-91.
26. Wanatabe I, Arai T, Ono M, Sugito M, Kawashima K, Ito M et al. Prognostic factors in resection of pulmonary metastasis from colorectal cancer. Br J Surg 2003;90: 1436-40.
27. Poston GJ. The use of irinotecan and oxaliplatin in the treatment of advanced colorectal cancer. Eur J Surg Oncol 2005;31:325-30.
28. Fernandez FG, Ritter J, Goodwin JW, Linehan DC, Hawkins WG, Strasberg SM. Effect of steatohepatitis associated with irinotecan or oxaliplatin pretreatment on resectability of hepatic colorectal metastases. J Am Coll Surg 2005;200:845-53.
29. Rubbia-Brandt L, Audard V, Sartoretti P, Roth AD, Brezault C, Le Charpentier M et al. Severe hepatic sinusoidal obstruction associated with oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer. Ann Oncol 2004;15:460-6.
30. Makuuchi M, Thai BL, Takayasu K, Takayama T, Kosuge T, Gunven P et al. Preoperative portal embolization to increase safety of major hepatectomy for hilar bile duct carcinoma: a preliminary report. Surgery 1990;107: 521-7.
31. Azoulay D, Castaing D, Smail A, Adam R, Cailliez V, Laurent A et al. Resection of nonresectable liver metastases from colorectal cancer after percutaneous portal vein embolization. Ann Surg 2000;231:480-6.
32. Nagino M, Kamiya J, Nishio H, Ebata T, Arai T, Nimura Y Two hundred forty consecutive portal vein embolizations before extended hepatectomy for biliary cancer. Surgical outcome and long-term follow-up. Ann Surg 2006;243:364-72.
33. Madoff DC, Abdalla EK, Vauthey JN. Portal vein embolization in preparation for major hepatic resection: evolution of a new standard of care. J Vasc Interv Radiol 2005;16:779-90.
34. Abdalla EK, Adam R, Bilchik AJ, Jaeck D, Vauthey JN, Mahvi D. Improving resectability of hepatic colorectal metastases: expert consensus statement. Ann Surg Oncol 2006;13:1271-80.
35. Aoki T, Imamura H, Hasegawa K, Matsukura A, Sano K, Sugawara Y et al. Sequential preoperative arterial and portal venous embolizations in patients with hepatocellular carcinoma. Arch Surg 2004;139:766-74.
36. Jaeck D, Oussoultzoglou E, Rosso E, Greget M, Weber JC, Bachellier P. A two-stage hepatectomy procedure combined with portal vein embolization to achieve curative resection for initially unresectable multiple and bilobar colorectal liver metastases. Ann Surg 2004;240:1037-51.
37. Di Stefano DR, de Baere T, Denys A, Hakime A, Gorin G, Gillet M et al. Preoperative percutaneous portal vein embolization: evaluation of adverse events in 188 patients. Radiology 2005;234:625-30.
38. Azoulay D, Castaing D, Smail A, Adam R, Cailliez V, Laurent A et al. Resection of nonresectable liver metastases from colorectal cancer after percutaneous portal vein embolization. Ann Surg 2000;231:480-6.
39. Elias D, Ouellet JF, De Baere T, Lasser P, Roche A. Preoperative selective portal vein embolization before hepatectomy for liver metastases: long-term results and impact on survival. Surgery 2002;131:294-9.
40. Torzilli G, Donadon M, Marconi M, Del Fabbro D, Palmisano A, Spinelli A et al. Ultrasound guided liver resection: does this approach limit the need for portal vein branch embolization? Ann Surg Oncol 2007;14(2 Suppl):23.
41. Adam R, Laurent A, Azoulay D, Castaing D, Bismuth H. Two-stage hepatectomy: a planned strategy to treat unresectable liver tumors. Ann Surg 2000;232:777-85.
42. Kianmanesh R, Farges O, Abdalla EK, Sauvanet A, Ruszniewski P, Belghiti J. Right portal vein ligation: a new planned two-step all-surgical approach for complete resection of primary gastrointestinal tumors with multiple bilateral liver metastases. J Am Coll Surg 2003;197:164-70.
43. Yamamoto J, Sugihara K, Kosuge T, Takayama T, Shimada K, Yamashaki S et al. Pathological support for limited hepatectomy in the treatment of liver metastases from colorectal cancer. Ann Surg 1995;221:74-8.
44. Elias D, Cavalcanti A, Sabourin JC, Pignon JP, Ducreux M, Lasser P. Results of 136 curative hepatectomies with a safety margin of less than 10 mm for colorectal metastases. J Surg Oncol 1998;69:88-93.
45. Kokudo N, Miki Y, Sugai S, Yanagisawa A, Kato Y, Sakamoto Y et al. Genetic and histological assessment of surgical margins in resected liver metastases from colorectal carcinoma: minimum surgical margins for successful resection. Arch Surg 2002;137:833-40.
46. Torzilli G, Montorsi M, Donadon M, Palmisano A, Del Fabbro D, Gambetti A et al. "Radical but conservative" is the main goal for ultrasonography-guided liver resection: prospective validation of this approach. J Am Coll Surg 2005;201:517-28.
47. Torzilli G, Palmisano A, Del Fabbro D, Donadon M, Montorsi M. Technical tricks for radical but conservative liver resection. The ultrasound guidance. Minerva Chir 2005;60:159-65.
48. Torzilli G, Montorsi M, Del Fabbro D, Palmisano A, Donadon M, Makuuchi M. Ultrasonographically guided surgical approach to liver tumours involving the hepatic veins close to the caval confluence. Br J Surg 2006;93:1238-46.
49. Torzilli G, Makuuchi M. Tricks for ultrasound-guided resection of colorectal liver metastases. Hepatogastroenterology 2003;50:1-3.
50. Imamura H, Seyama Y, Kokudo N, Maema A, Sugawara Y, Sano K et al. One thousand fifty-six hepatectomies without mortality in 8 years. Arch Surg 2003;138:1198-206.
51. Gayowski TJ, Iwatsuki S, Madariaga JR, Selby R, Todo S, Irish W et al. Experience in hepatic resection for metastatic colorectal cancer: analysis of clinical and pathologic risk factors. Surgery 1994;116:703-10.
52. Scheele J, Stang R, Altendorf-Hofmann A, Paul M. Resection of colorectal liver metastases. World J Surg 1995;19:59-71.
53. Nordlinger B, Guiguet M, Vaillant JC, Balladur P, Boudjema K, Bachellier P et al. Surgical resection of colorectal carcinoma metastases to the liver. A prognostic scoring system to improve case selection, based on 1568 patients. Association Francaise de Chirurgie. Cancer 1996;77:1254-62.
54. Jaeck D, Bachellier P, Guiguet M, Boudjema K, Vaillant JC, Balladur P et al. Long-term survival following resection of colorectal hepatic metastases. Association Francaise de Chirurgie. Br J Surg 1997;84:977-80.
55. Jamison RL, Donohue JH, Nagomey DM, Rosen CB, Harmsen WS, Ilstrup DM. Hepatic resection for metastatic colorectal cancer results in cure for some patients. Arch Surg 1997;132:505-10.
56. Jenkins LT, Millikan KW, Bines SD, Staren ED, Doolas A. Hepatic resection for metastatic colorectal cancer. Am Surg 1997;63:605-10.
57. Elias D, Cavalcanti de Albuquerque A, Eggenspieler P, Plaud B, Ducreux M, Spielmann M et al. Resection of liver metastases from a noncolorectal primary: indications and results based on 147 monocentric patients. J Am Coll Surg 1998;187:487-93.
58. Ambiru S, Miyazaki M, Isono T, Ito H, Nakagawa K, Shimizu H et al. Hepatic resection for colorectal metastases: analysis of prognostic factors. Dis Colon Rectum 1999;42:632-9.
59. Fong Y, Fortner J, Sun RL, Brennan MF, Blumgart LH. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg 1999;230:309-18.
60. Figueras J, Vails C, Rafecas A, Fabregat J, Ramos E, Jaurrieta E. Resection rate and effect of postoperative chemotherapy on survival after surgery for colorectal liver metastases. Br J Surg 2001;88:980-5.
61. Adam R, Pascal G, Azoulay D, Tanaka K, Castaing D, Bismuth H. Liver resection for colorectal metastases: the third hepatectomy. Ann Surg 2003;238:871-83.
62. Aloia TA, Vauthey JN, Loyer EM, Ribero D, Pawlik TM, Wei SH. Solitary colorectal liver metastasis. Resection determines outcome. Arch Surg 2006;141:460-7.
63. de Baere T, Risse O, Kuoch V, Dromain C, Sengel C, Smayra T et al. Adverse events during radiofrequency treatment of 582 hepatic tumors. AJR Am J Roentgenol 2003;181:695-700.
64. Nikfarjam M, Muralidharan V, Christophi C. Altered growth patterns of colorectal liver metastases after thermal ablation. Surgery 2006;139:73-81.
65. Torzilli G, Del Fabbro D, Palmisano A, Marconi M, Makuuchi M, Montorsi M. Salvage hepatic resection after incomplete interstitial therapy for primary andsecondary liver tumours. Br J Surg 2007;94:208-13.